Literature DB >> 18157638

Response to hepatitis B vaccination in patients with celiac disease.

Emel Ahishali1, Gungor Boztas, Filiz Akyuz, Duygu Ibrisim, Sule Poturoglu, Binnur Pinarbasi, Sadakat Ozdil, Zeynel Mungan.   

Abstract

Abnormal immune response to gliadin, genetic, and environmental factors play a role in the pathogenesis of celiac disease (CD). Non-responsiveness to hepatitis B virus (HBV) vaccination is related to genetic features. Certain human leukocyte antigen (HLA) genotypes are more prevalent among non-responders to HBV vaccination. There is also a strong relationship between CD and these HLA genotypes. This study investigates the relationship between CD and non-responsiveness to HBV vaccination, with an emphasis on genotypic co-incidence. No statistically significant difference was noted between the ages and gender of CD patients and control subjects. Baseline serum IgA, IgM, and IgG levels of all CD patients were normal. Responsiveness to HBV vaccination was observed in 17 (68%) CD patients and all (100%) control subjects (P = 0.006). In conclusion, CD should also be sought in unresponders to HBV vaccine who are not immunosuppressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18157638     DOI: 10.1007/s10620-007-0128-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

Review 1.  The widening spectrum of celiac disease.

Authors:  J A Murray
Journal:  Am J Clin Nutr       Date:  1999-03       Impact factor: 7.045

2.  The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.

Authors:  David N Fisman; Deepak Agrawal; Karin Leder
Journal:  Clin Infect Dis       Date:  2002-11-12       Impact factor: 9.079

3.  Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.

Authors:  Kunal Das; R K Gupta; V Kumar; P Kar
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 4.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

5.  C4A deficiency and nonresponse to hepatitis B vaccination.

Authors:  Thomas Höhler; Beate Stradmann-Bellinghausen; Roland Starke; Roland Sänger; Anja Victor; Christian Rittner; Peter M Schneider
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

6.  Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and nonresponder vaccine recipients.

Authors:  K W Schuenke; R G Cook; R R Rich
Journal:  Hum Immunol       Date:  1998-12       Impact factor: 2.850

7.  HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination.

Authors:  Chengbin Wang; Jianming Tang; Wei Song; Elena Lobashevsky; Craig M Wilson; Richard A Kaslow
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

8.  Hepatitis B vaccine nonresponse and celiac disease.

Authors:  Kyung W Noh; Gregory A Poland; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

Review 9.  A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.

Authors:  Emmet B Keeffe; Douglas T Dieterich; Steve-Huy B Han; Ira M Jacobson; Paul Martin; Eugene R Schiff; Hillel Tobias; Teresa L Wright
Journal:  Clin Gastroenterol Hepatol       Date:  2004-02       Impact factor: 11.382

10.  Human hepatitis B vaccine from recombinant yeast.

Authors:  W J McAleer; E B Buynak; R Z Maigetter; D E Wampler; W J Miller; M R Hilleman
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

View more
  20 in total

1.  Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen.

Authors:  Celine A Hayden; Stephen J Streatfield; Barry J Lamphear; Gina M Fake; Todd K Keener; John H Walker; John D Clements; Debra D Turner; Ian R Tizard; John A Howard
Journal:  Vaccine       Date:  2012-03-08       Impact factor: 3.641

Review 2.  Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.

Authors:  Giovanna Vitaliti; Andrea Domenico Praticò; Carla Cimino; Giovanna Di Dio; Elena Lionetti; Mario La Rosa; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Production of highly concentrated, heat-stable hepatitis B surface antigen in maize.

Authors:  Celine A Hayden; Erin M Egelkrout; Alessa M Moscoso; Cristina Enrique; Todd K Keener; Rafael Jimenez-Flores; Jeffrey C Wong; John A Howard
Journal:  Plant Biotechnol J       Date:  2012-07-21       Impact factor: 9.803

Review 5.  Immune response to Hepatitis B vaccine in patients with celiac disease: A systematic review and meta-analysis.

Authors:  R Opri; D Veneri; C Mengoli; G Zanoni
Journal:  Hum Vaccin Immunother       Date:  2015-09-17       Impact factor: 3.452

6.  Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen.

Authors:  Celine A Hayden; Emily M Smith; Debra D Turner; Todd K Keener; Jeffrey C Wong; John H Walker; Ian R Tizard; Rafael Jimenez-Flores; John A Howard
Journal:  Vaccine       Date:  2014-01-28       Impact factor: 3.641

7.  Influence of the microbiome on response to vaccination.

Authors:  Amanda M Jamieson
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Immune response to hepatitis B virus vaccine in celiac subjects at diagnosis.

Authors:  Martina Filippelli; Maria Teresa Garozzo; Antonino Capizzi; Massimo Spina; Sara Manti; Lucia Tardino; Carmelo Salpietro; Salvatore Leonardi
Journal:  World J Hepatol       Date:  2016-09-18

9.  Role of gluten intake at the time of hepatitis B virus vaccination in the immune response of celiac patients.

Authors:  F Zingone; P Capone; R Tortora; A Rispo; F Morisco; N Caporaso; N Imperatore; G De Stefano; P Iovino; C Ciacci
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

10.  Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.

Authors:  Salvatore Leonardi; Andrea Domenico Praticò; Elena Lionetti; Massimo Spina; Giovanna Vitaliti; Mario La Rosa
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.